HRP20150639T1 - Postupak za proäśišä†avanje proteina - Google Patents
Postupak za proäśišä†avanje proteina Download PDFInfo
- Publication number
- HRP20150639T1 HRP20150639T1 HRP20150639TT HRP20150639T HRP20150639T1 HR P20150639 T1 HRP20150639 T1 HR P20150639T1 HR P20150639T T HRP20150639T T HR P20150639TT HR P20150639 T HRP20150639 T HR P20150639T HR P20150639 T1 HRP20150639 T1 HR P20150639T1
- Authority
- HR
- Croatia
- Prior art keywords
- host cell
- recombinant
- recombinant protein
- seq
- extract
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 27
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 13
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 13
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 claims 6
- 108020003519 protein disulfide isomerase Proteins 0.000 claims 6
- 230000001580 bacterial effect Effects 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- 108010016626 Dipeptides Proteins 0.000 claims 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 2
- 238000004587 chromatography analysis Methods 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 102000014914 Carrier Proteins Human genes 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 108091008324 binding proteins Proteins 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 239000011536 extraction buffer Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000012362 glacial acetic acid Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 102000057041 human TNF Human genes 0.000 claims 1
- 238000004255 ion exchange chromatography Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Claims (25)
1. Postupak za pročišćavanje rekombinantnog proteina iz gram-negativnog bakterijskog uzorka stanice domaćina ili njezinog ekstrakta pri čemu navedena stanica domaćina izražava rekombinantni protein i rekombinantnu disulfid izomerazu DsbC; pri čemu postupaka sadrži:
a) podešavanje pH uzorka stanice domaćina, ili njezinog ekstrakta do pH 5 ili manje da se istaloži rekombinantna disulfid izomeraza; i
b) odvajanje istaložene rekombinantne disulfid izomeraze iz rekombinantnog proteina da se proizvede uzorak rekombinantnog proteina.
2. Postupak prema patentnom zahtjevu 1, pri čemu je pH uzorka stanice domaćina ili njezinog ekstrakta podešen na pH od 4.5 ili manje.
3. Postupak prema patentnom zahtjevu 2, pri čemu je pH uzorka stanice domaćina ili njezinog ekstrakta podešen na pH od 4.5 do 3.0.
4. Postupak prema patentnom zahtjevu 2, pri čemu je pH uzorka stanice domaćina ili njezinog ekstrakta podešen na pH od 3 ili manje.
5. Postupak prema patentnom zahtjevu 4, pri čemu je u koraku a) dipeptid stanice domaćina vezujućeg proteina dalje istaložen i u koraku b) dipeptid stanice domaćina je dalje odvojen od rekombinantnog proteina.
6. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu disulfid izomeraza sadrži dodatak histidina.
7. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu je gram-negativna bakterijska stanica domaćina E. coli.
8. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu stanica domaćina sadrži Fkpa i/ili Skp.
9. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu u koraku a) pH uzorka stanice domaćina ili njezinog ekstrakta je podešen na pH od manje od 5 upotrebom ledene octene kiseline.
10. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu uzorak stanice domaćina ili njezinog ekstrakta se drži na pH od 5 ili manje tokom jednog sata ili manje.
11. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu separacija u koraku b) sadrži centrifugiranje i/ili filtriranje.
12. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu nakon koraka b) postupak sadrži dalji korak pročišćavanja uzorka rekombinantnog proteina kromatografijom.
13. Postupak prema patentnom zahtjevu 11, pri čemu je kromatografija kromatografija ionske izmjene.
14. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu nakon koraka b) pH uzorka rekombinantnog proteina je podešena na pH od 5 do 7.
15. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu pre koraka a) pufer za ekstrakciju je dodat uzorku stanice domaćina ili njegovom ekstraktu i uzorak stanice domaćina ili njegov ekstrakt je podvrgnut koraku termičke obrade.
16. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu rekombinantni protein ima pl od 6 do 9.
17. Postupak prema patentnom zahtjevu 16, pri čemu rekombinantni protein ima pl od 8 do 9.
18. Postupak prema bilo kojem od prethodnih patentnih zahtjeva, pri čemu rekombinantni protein je rekombinantno antitijelo.
19. Postupak prema patentnom zahtjevu 18, pri čemu je rekombinantno antitijelo monoklonalno, humanizirano ili himerno antitijelo, ili njihov fragment, kao što je njihov vezujući fragment.
20. Postupak prema patentnom zahtjevu 18 ili zahtjevu 19, pri čemu je rekombinantno antitijelo Fab ili Fab fragment.
21. Postupak prema bilo kojem od patentnih zahtjeva 18 do 20, pri čemu je rekombinantno antitijelo specifično za humani TNFɑ.
22. Postupak prema patentnom zahtjevu 21, pri čemu antitijelo sadrži teški lanac gdje varijabilna domena sadrži CDR koji ima sekvencu danu u SEQ ID NO:1 za CDRH1, SEQ ID NO:2, za CDRH2 i SEQ ID NO:3 za CDRH3 i laki lanac pri čemu varijabilna domena sadrži CDR koji ima sekvencu danu u SEQ ID NO:4 za CDRL1, SEQ ID NO:5 za CDRL2 i SEQ ID NO:6 za CDRL3.
23. Postupak prema patentnom zahtjevu 22, pri čemu antitijelo sadrži sekvencu varijabilne regije lakog lanca danu u SEQ ID NO: 7 i varijabilna regija teškog lanca je dana u SEQ ID NO: 8.
24. Postupak prema patentnom zahtjevu 23, pri čemu je antitijelo Fab fragment i sadrži teški lanac koji ima sekvencu danu u SEQ ID NO: 10 i laki lanac koji ima sekvencu danu u SEQ ID NO: 9.
25. Upotreba koraka podešavanja pH gram-negativnog bakterijskog uzorka stanice domaćina ili njezinog ekstrakta transformiranog ekspresijskim vektorom koji kodira rekombinantni protein na pH 5 ili manje kako bi se istaložila rekombinantna disulfid izomeraza stanice domaćina, odvojila istaložena rekombinantna disulfid izomeraza stanice domaćina iz rekombinantnog proteina i proizveo pročišćeni uzorak rekombinantnog proteina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1012599.5A GB201012599D0 (en) | 2010-07-27 | 2010-07-27 | Process for purifying proteins |
| PCT/GB2011/001129 WO2012013930A2 (en) | 2010-07-27 | 2011-07-27 | Process for purifying proteins |
| EP11745810.9A EP2598516B8 (en) | 2010-07-27 | 2011-07-27 | Process for purifying proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20150639T1 true HRP20150639T1 (hr) | 2015-07-17 |
Family
ID=42752868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20150639TT HRP20150639T1 (hr) | 2010-07-27 | 2015-06-15 | Postupak za proäśišä†avanje proteina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9751930B2 (hr) |
| EP (1) | EP2598516B8 (hr) |
| JP (1) | JP5935222B2 (hr) |
| KR (1) | KR101944121B1 (hr) |
| CN (1) | CN103189385B (hr) |
| AU (1) | AU2011284548B2 (hr) |
| BR (1) | BR112013000177B1 (hr) |
| CA (1) | CA2804099C (hr) |
| CY (1) | CY1116526T1 (hr) |
| DK (1) | DK2598516T3 (hr) |
| ES (1) | ES2537877T3 (hr) |
| GB (1) | GB201012599D0 (hr) |
| HR (1) | HRP20150639T1 (hr) |
| HU (1) | HUE026049T2 (hr) |
| IL (1) | IL224044A (hr) |
| ME (1) | ME02162B (hr) |
| MX (1) | MX337184B (hr) |
| PL (1) | PL2598516T3 (hr) |
| PT (1) | PT2598516E (hr) |
| RS (1) | RS54085B1 (hr) |
| SG (2) | SG186974A1 (hr) |
| SI (1) | SI2598516T1 (hr) |
| SM (1) | SMT201500142B (hr) |
| WO (1) | WO2012013930A2 (hr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9109216B2 (en) | 2009-09-24 | 2015-08-18 | Ucb Pharma, S.A. | Bacterial host strain |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| HUE035674T2 (en) | 2011-07-13 | 2018-05-28 | Ucb Biopharma Sprl | Bacterial host strains expressing recombinant DSBC |
| GB201208367D0 (en) * | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
| CN104487446B (zh) | 2012-05-31 | 2018-05-29 | 新加坡科技研究局 | 利用混合的多官能性表面降低蛋白制剂中聚集物含量的方法 |
| CN104507955A (zh) | 2012-05-31 | 2015-04-08 | 新加坡科技研究局 | 采用具有多形式官能性的颗粒对免疫球蛋白g制备物的色谱纯化 |
| WO2016102383A1 (en) * | 2014-12-22 | 2016-06-30 | Ucb Biopharma Sprl | Protein manufacture |
| BR112017013398B1 (pt) | 2014-12-22 | 2023-12-05 | Ucb Biopharma Sprl | Método de fabricar anticorpo ou fragmento de ligação ao antígeno do mesmo |
| CN107531749A (zh) * | 2015-03-06 | 2018-01-02 | 豪夫迈·罗氏有限公司 | 超纯化DsbA和DsbC及其制备和使用方法 |
| CN110272491B (zh) * | 2018-03-13 | 2023-01-24 | 江苏恒瑞医药股份有限公司 | 一种抗pd-1抗体的纯化工艺 |
| CN114829578A (zh) * | 2019-08-05 | 2022-07-29 | 瓦克化学股份公司 | 用于在发酵方法中释放重组蛋白的细菌菌株 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
| US5030570A (en) | 1988-06-30 | 1991-07-09 | The Eunice Kennedy Shriver Center For Mental Retardation | DNA encoding and method of expressing human monoamine oxidase type A |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8907617D0 (en) | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| EP0542810A1 (en) | 1990-08-02 | 1993-05-26 | B.R. Centre Limited | Methods for the production of proteins with a desired function |
| US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
| US5264365A (en) | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
| GB9112536D0 (en) | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
| GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
| GB9120467D0 (en) | 1991-09-26 | 1991-11-06 | Celltech Ltd | Anti-hmfg antibodies and process for their production |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| GB9215540D0 (en) | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
| WO1997038123A1 (en) * | 1996-04-05 | 1997-10-16 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| CA2377491C (en) | 1999-06-29 | 2008-01-29 | Siga Technologies, Inc. | Assay for degp protease inhibitors |
| GB0006398D0 (en) | 2000-03-16 | 2000-05-03 | Novartis Ag | Organic compounds |
| GB0013810D0 (en) * | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| AU8867501A (en) | 2000-09-01 | 2002-03-13 | Biogen Inc | Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| EP1314037A2 (en) | 2000-09-01 | 2003-05-28 | Biogen, Inc. | Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| US7041479B2 (en) * | 2000-09-06 | 2006-05-09 | The Board Of Trustess Of The Leland Stanford Junior University | Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| CA2430249A1 (en) | 2000-12-14 | 2002-06-20 | Genentech, Inc. | Bacterial host strains |
| DE60135498D1 (de) | 2000-12-14 | 2008-10-02 | Genentech Inc | Produktion von ganzen Antikörpern in prokaryontischen Zellen |
| TWI334439B (en) | 2001-08-01 | 2010-12-11 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
| KR100968664B1 (ko) | 2001-08-27 | 2010-07-06 | 제넨테크, 인크. | 항체 발현 및 조립을 위한 시스템 |
| GB0124317D0 (en) | 2001-10-10 | 2001-11-28 | Celltech R&D Ltd | Biological products |
| MXPA04004634A (es) | 2001-11-16 | 2004-08-12 | Idec Pharma Corp | Expresion policistronica de anticuerpos. |
| GB0129105D0 (en) | 2001-12-05 | 2002-01-23 | Celltech R&D Ltd | Expression control using variable intergenic sequences |
| PT1517921E (pt) | 2002-06-28 | 2006-09-29 | Domantis Ltd | Ligandos duplamente especificos com semi-vida no soro aumentada |
| CA2499300A1 (en) * | 2002-10-31 | 2004-05-21 | Genentech, Inc. | Methods and compositions for increasing antibody production |
| PT1570267E (pt) | 2002-12-03 | 2012-01-03 | Ucb Pharma Sa | Ensaio para a identificação de células produtoras de anticorpos |
| JP2006517415A (ja) | 2003-01-09 | 2006-07-27 | ジェネンテック・インコーポレーテッド | ポリペプチドの精製 |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| ATE482235T1 (de) | 2003-06-13 | 2010-10-15 | Biogen Idec Inc | Aglycosyl-anti-cd154 (cd40-ligand) antikörper und deren verwendungen |
| SI1639011T1 (sl) | 2003-06-30 | 2009-04-30 | Domantis Ltd | Pegilirana protitelesa z enojno domeno (dAb) |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| AU2004261198A1 (en) | 2003-07-26 | 2005-02-10 | Biogen Idec Ma Inc. | Altered antibodies having improved antigen-binding affinity |
| EA014226B1 (ru) | 2004-07-26 | 2010-10-29 | Байоджен Айдек Ма Инк. | Антитела к cd154, их фрагменты и способы применения антител и фрагментов |
| AU2005282700A1 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| GB0425534D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
| CN101679521B (zh) | 2007-03-22 | 2014-03-12 | 拜奥根Idec马萨诸塞公司 | 特异性结合cd154的包括抗体、抗体衍生物和抗体片段在内的结合蛋白及其用途 |
| US7662587B1 (en) | 2009-03-05 | 2010-02-16 | E. I. Du Pont De Nemours And Company | Gene knockout mutations that increase peptide production |
| US9109216B2 (en) | 2009-09-24 | 2015-08-18 | Ucb Pharma, S.A. | Bacterial host strain |
| US8470552B2 (en) | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| NZ598901A (en) | 2009-11-05 | 2014-08-29 | Genentech Inc | Methods and composition for secretion of heterologous polypeptides |
| GB201000588D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| HUE035674T2 (en) | 2011-07-13 | 2018-05-28 | Ucb Biopharma Sprl | Bacterial host strains expressing recombinant DSBC |
| EP2546267A1 (en) | 2011-07-13 | 2013-01-16 | UCB Pharma S.A. | Bacterial host strain expressing recombinant DsbC |
| GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
-
2010
- 2010-07-27 GB GBGB1012599.5A patent/GB201012599D0/en not_active Ceased
-
2011
- 2011-07-27 SI SI201130516T patent/SI2598516T1/sl unknown
- 2011-07-27 PT PT117458109T patent/PT2598516E/pt unknown
- 2011-07-27 ME MEP-2015-94A patent/ME02162B/me unknown
- 2011-07-27 SG SG2013001318A patent/SG186974A1/en unknown
- 2011-07-27 WO PCT/GB2011/001129 patent/WO2012013930A2/en active Application Filing
- 2011-07-27 CA CA2804099A patent/CA2804099C/en active Active
- 2011-07-27 US US13/812,350 patent/US9751930B2/en active Active
- 2011-07-27 PL PL11745810T patent/PL2598516T3/pl unknown
- 2011-07-27 JP JP2013521208A patent/JP5935222B2/ja active Active
- 2011-07-27 RS RS20150429A patent/RS54085B1/en unknown
- 2011-07-27 HU HUE11745810A patent/HUE026049T2/en unknown
- 2011-07-27 SG SG2014005441A patent/SG196862A1/en unknown
- 2011-07-27 AU AU2011284548A patent/AU2011284548B2/en active Active
- 2011-07-27 CN CN201180036417.8A patent/CN103189385B/zh active Active
- 2011-07-27 EP EP11745810.9A patent/EP2598516B8/en active Active
- 2011-07-27 BR BR112013000177-1A patent/BR112013000177B1/pt not_active IP Right Cessation
- 2011-07-27 ES ES11745810.9T patent/ES2537877T3/es active Active
- 2011-07-27 MX MX2013000899A patent/MX337184B/es active IP Right Grant
- 2011-07-27 DK DK11745810.9T patent/DK2598516T3/da active
- 2011-07-27 KR KR1020137004911A patent/KR101944121B1/ko active IP Right Grant
-
2012
- 2012-12-31 IL IL224044A patent/IL224044A/en active IP Right Grant
-
2015
- 2015-06-15 HR HRP20150639TT patent/HRP20150639T1/hr unknown
- 2015-06-18 SM SM201500142T patent/SMT201500142B/xx unknown
- 2015-06-23 CY CY20151100535T patent/CY1116526T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20150639T1 (hr) | Postupak za proäśišä†avanje proteina | |
| HRP20180226T1 (hr) | Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc | |
| RU2016119152A (ru) | Стабильные и растворимые антитела, ингибирующие vegf | |
| JP2018521638A5 (hr) | ||
| US10149903B2 (en) | Fully human antibody against respiratory syncytical virus | |
| HRP20200464T1 (hr) | Metoda modifikacije polipeptida za pročišćavanje polipeptidnih multimera | |
| HRP20180516T1 (hr) | Humanizirana protutijela specifična za protofibrilni oblik amiloidnog-beta peptida | |
| JP2018085988A5 (hr) | ||
| RU2017125758A (ru) | Антитела к с5 и способы их применения | |
| RU2015150149A (ru) | Составы на основе биспецифических антител к il-4/il-13 | |
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| RU2014146503A (ru) | Белки, связывающие антиген - лиганд cd30 человека | |
| AR068566A1 (es) | Proteinas fijadoras de antigeno de factor de crecimiento del tipo factor de crecimiento epidermico fijador de heparina | |
| PE20090518A1 (es) | Proteinas enlazantes de antigenos que enlazan al receptor de la interleucina 18 (il-18) | |
| NZ603972A (en) | Anti-fgfr2 antibodies | |
| JP2011528902A5 (hr) | ||
| IL259940B2 (en) | A method for treating or improving metabolic disorders using gastric inhibitory peptide receptor binding proteins in combination with glucagon-like peptide 1 agonists | |
| CL2013003140A1 (es) | Un anticuerpo monoclonal humano aislado o fragmento de union a antigeno del mismo que se une a masp-2 humana; molecula de acido nucleico, casette de expresion, celula que la expresa, metodo de produccion, composicion que la contiene, articulo que lo contiene. | |
| PE20141660A1 (es) | PROTEINAS DE UNION A ANTIGENO DE TNF-ALFA CON UNION A FcRn INCREMENTADA | |
| RU2013140350A (ru) | Антитела против человеческого il33r и их применение | |
| NZ601583A (en) | Novel rabbit antibody humanization methods and humanized rabbit antibodies | |
| NZ600768A (en) | Human antibodies to human angiopoietin-like protein 4 | |
| JP2011527899A5 (hr) | ||
| BR112014015101A8 (pt) | métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorpos | |
| RU2013124808A (ru) | Новое антитело против dr5 |